The Italian government has controversially reclassified cannabidiol (CBD) as a narcotic. This latest development is another twist in the ongoing regulatory saga around the hemp-derived compound in the European country.

Despite the global CBD market forecasting a growth from 4.9 Billion in 2022 to 47.22 billion by 2030, Italy seems to be taking a step back. The current anticipated CAGR for the industry stands at 21.2%.

See Also: Italy Sparks Controversy by Reclassifying Oral CBD as a Narcotic: Uncertainty and Debate in the European Market


Historically, the regulatory position in Italy has been inconsistent.

In 2020, a decree was issued tagging CBD as a narcotic, only to be repealed shortly after. A subsequent …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.